Schmoele-Thoma, B., Falsey, A. R., Walsh, E. E., Swanson, K., Zareba, A., Cooper, D., . . . Dormitzer, P. R. (2019). 2755. Phase 1/2, First-in-Human Study of the Safety, Tolerability, and Immunogenicity of an RSV Prefusion F-Based Subunit Vaccine Candidate. Open Forum Infect Dis.
Citação norma ChicagoSchmoele-Thoma, Beate, et al. "2755. Phase 1/2, First-in-Human Study of the Safety, Tolerability, and Immunogenicity of an RSV Prefusion F-Based Subunit Vaccine Candidate." Open Forum Infect Dis 2019.
Citação norma MLASchmoele-Thoma, Beate, et al. "2755. Phase 1/2, First-in-Human Study of the Safety, Tolerability, and Immunogenicity of an RSV Prefusion F-Based Subunit Vaccine Candidate." Open Forum Infect Dis 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.